S
ISSUER//CIK 0000911326
SYNAGEVA BIOPHARMA CORP
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 10-K/A375.6 KBTRIMERIS INCMay 2, 12:46 PM ET·0001193125-05-091737
- 45.9 KBTRIMERIS INCMay 2, 12:16 PM ET·0001181431-05-024501
- 8-K11.4 KBTRIMERIS INCFeb 7, 5:11 PM ET·0001181431-05-007570
- 8-K40.8 KBTRIMERIS INCDec 3, 5:04 PM ET·0001193125-04-207379
- 8-K42.1 KBTRIMERIS INCOct 20, 2:45 PM ET·0001193125-04-174423
- 8-K25.7 KBTRIMERIS INCOct 15, 1:46 PM ET·0001193125-04-172216
- 10-K/A105.7 KBTRIMERIS INCOct 15, 1:44 PM ET·0001193125-04-172206
- 10-Q/A57.6 KBTRIMERIS INCOct 15, 1:42 PM ET·0001193125-04-172200
- 8-K12.6 KBTRIMERIS INCSep 23, 3:23 PM ET·0001193125-04-160800
- 8-K12.7 KBTRIMERIS INCSep 2, 4:08 PM ET·0001193125-04-151356
Insiders
10- Baker Biotech Capital (GP), LLC10% Owner
- Baker Biotech Capital II (GP), LLC10% Owner
- Baker Bros. Capital (GP), LLC10% Owner
- BAKER FELIX10% Owner
- BAKER JULIAN10% Owner
- BOLOGNESI DANI PDirector, Chief Scientific Officer
- BONCZEK ROBERT RCFO and General Counsel
- Graham Andrew LDirector of Finance
- Koszalka George WEVP of Scientific Operations
- SANDERS CHARLES ADirector
Tickers
No tickers on record
Addresses
business
33 HAYDEN AVE.
LEXINGTON, MA, 02421
mailing
33 HAYDEN AVE.
LEXINGTON, MA, 02421
Former Names
- TRIMERIS INC2011-10-13